David Knop

David Knop is an executive-level biotech veteran with over 19 years of experience in the field of gene therapy and process development. Currently serving as the VP of Preclinical Manufacturing & Process Development at Asklepios BioPharmaceutical, Inc. since March 2023, David previously held various senior roles at AGTC from March 2004 to March 2023, including SVP Process & Assay Development and Vice President of Process Development. David's expertise encompasses comprehensive CMC responsibility for AAV gene therapy clinical programs, with a focus on late-phase material manufacturing for rare ocular diseases, as well as managing processes for multiple Phase 1 and 2 clinical programs. David's educational background includes a Doctorate in (Bio)Chemical Engineering and a Bachelor of Science in Chemical Engineering, both from Michigan State University.